Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their developers with both rich remuneration and ...
Medpage Today on MSN8d
GLP-1 Agents and Suicide: Making Sense of 2024's Mixed DataNot long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...
These weight management drugs, which mimic natural hormones that regulate insulin and glucose levels, have become increasingly popular due to their effectiveness in promoting weight loss. However, ...
HealthDay on MSN3d
How do GLP-1s Boost Weight Loss, Heart Health?Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-los ...
The new packaging, intended to benefit semaglutide users, will be rolled out in January — but experts say “it will be up to ...
The MHRA warns against buying weight-loss medicines illegally, emphasizing health risks and the need for prescriptions from ...
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
The history of breakthrough weight loss medicines is riddled with tragic results. Based on the histories of phen-fen and ...
GLP-1 receptor agonists emerge as promising therapies for MASLD, addressing metabolic dysfunction and offering potential improvements in liver health and fibrosis management. Study: Current Status ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback